Overview
Malignant aortic body tumors (MATs) are extremely rare neoplasms arising from the aortic tissue, typically presenting with nonspecific symptoms such as chest pain and dyspnea. Due to their rarity, comprehensive treatment guidelines are limited, and outcomes are generally poor 1.Diagnosis
Clinical Presentation: Often includes chest pain, dyspnea, and weight loss 1.
Imaging: CT and MRI are crucial for tumor localization and assessment of extent 1.
Histopathology: Essential for definitive diagnosis, distinguishing between various subtypes like angiosarcoma or other malignant sarcomas 1.
Laboratory Tests: Routine blood tests may show nonspecific abnormalities; specific tumor markers are not typically utilized 1.Management
Surgical Resection: Primary treatment when feasible, aiming for complete tumor removal 1.
Adjuvant Therapy: Chemotherapy and radiation therapy are considered adjunctively, though specific regimens are not detailed in the abstract 1.
Palliative Care: Important for symptom management in inoperable cases 1.Special Populations
Elderly: Limited data; treatment decisions heavily influenced by comorbidities and functional status 1.
Comorbidities: Presence of significant comorbidities may preclude aggressive surgical interventions 1.Key Recommendations
Surgical resection should be considered when feasible for localized disease (Evidence: Moderate 1).
Adjuvant chemotherapy and radiation therapy should be evaluated on a case-by-case basis (Evidence: Weak 1).
Palliative care should be integrated early in the management plan for patients with inoperable disease (Evidence: Expert opinion 1).References
1 Vacirca A, Faggioli G, Pini R, Freyrie A, Indelicato G, Fenelli C et al.. Predictors of survival in malignant aortic tumors. Journal of vascular surgery 2020. link